Ning Ding

3.8k total citations · 2 hit papers
57 papers, 2.0k citations indexed

About

Ning Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Ning Ding has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Immunology. Recurrent topics in Ning Ding's work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Ning Ding is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Ning Ding collaborates with scholars based in China, United States and Australia. Ning Ding's co-authors include Ronald M. Evans, Michael Downes, Christopher Liddle, Mara H. Sherman, Ruth T. Yu, Mathias Leblanc, Annette R. Atkins, Ming‐Xiao He, Sally Coulter and Thomas G. Boyer and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ning Ding

54 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response

2013 490 citations Ning Ding, Ruth T. Yu et al. Cell profile →
Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?

2023 81 citations Lei Li, Ning Ding et al. Antioxidants profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ning Ding China	20	925	340	336	316	243	57	2.0k
Kang Liu China	25	1.3k 1.4×	331 1.0×	216 0.6×	235 0.7×	229 0.9×	89	2.3k
Jeong A. Kim South Korea	22	678 0.7×	200 0.6×	110 0.3×	278 0.9×	164 0.7×	59	1.9k
Hao Hu China	29	993 1.1×	279 0.8×	148 0.4×	341 1.1×	214 0.9×	70	2.1k
Chuanrui Xu China	23	1.0k 1.1×	542 1.6×	146 0.4×	283 0.9×	552 2.3×	53	2.3k
Takeshi Hara Japan	26	966 1.0×	413 1.2×	213 0.6×	233 0.7×	144 0.6×	111	2.1k
Zhiying Yang China	23	533 0.6×	502 1.5×	88 0.3×	256 0.8×	369 1.5×	104	1.9k
Yoko Endo Japan	20	783 0.8×	406 1.2×	126 0.4×	218 0.7×	353 1.5×	53	2.0k
Dian-Chun Fang China	26	811 0.9×	294 0.9×	133 0.4×	161 0.5×	591 2.4×	100	1.7k
Urszula Mazurek Poland	22	634 0.7×	229 0.7×	107 0.3×	231 0.7×	326 1.3×	201	1.8k
Andrea Bábelová Germany	23	1.1k 1.2×	213 0.6×	173 0.5×	177 0.6×	221 0.9×	46	2.7k

Countries citing papers authored by Ning Ding

Since Specialization

Citations

This map shows the geographic impact of Ning Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ding more than expected).

Fields of papers citing papers by Ning Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ding. The network helps show where Ning Ding may publish in the future.

Co-authorship network of co-authors of Ning Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Ding. A scholar is included among the top collaborators of Ning Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Ding. Ning Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xinyi, et al.. (2025). SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus. Frontiers in Immunology. 16. 1530534–1530534. 8 indexed citations

Li, Bolin, Ning Ding, Peining Liu, et al.. (2025). Targeting FXR in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk. Blood. 146(20). 2464–2478.

Xing, Huijie, Ning Ding, Weifeng Feng, et al.. (2025). Nanometerizing Taxifolin Into Selenized Liposomes to Ameliorate Its Hypoglycemic Effect by Optimizing Drug Release and Bioavailability. International Journal of Nanomedicine. Volume 20. 2225–2240.

Ding, Ning, et al.. (2024). Macrocyclic-based strategy in drug design: From lab to the clinic. European Journal of Medicinal Chemistry. 277. 116733–116733. 7 indexed citations

Ding, Ning, Pengwu Xu, Weijun Yang, et al.. (2024). Synchronous Toughening, Strengthening, and Ultraviolet Resistance of Immiscible Polylactic Acid/polypropylene Carbonate Blends Compatibilized by a Low Threshold of Reactive Janus Nanosheets. Macromolecules. 57(24). 11407–11416. 12 indexed citations

Chen, Jin, Xu Li, Xueqing Zhang, et al.. (2023). Discovery of a natural small-molecule AMP-activated kinase activator that alleviates nonalcoholic steatohepatitis. Marine Life Science & Technology. 5(2). 196–210. 23 indexed citations

Jung, Min, Alessia Balestrini, Jonas Doerr, et al.. (2023). Single-Cell Transcriptomic Analysis Links Nonmyelinating Schwann Cells to Proinflammatory Response in the Lung. The Journal of Immunology. 211(5). 844–852. 5 indexed citations

Ma, Hsiao‐Yen, Qingling Li, Weng Ruh Wong, et al.. (2023). LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung. Science Advances. 9(21). eadf0133–eadf0133. 27 indexed citations

Li, Lei, et al.. (2023). Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?. Antioxidants. 12(4). 967–967. 81 indexed citations breakdown →

10.

Ma, Hsiao‐Yen, Jason A. Vander Heiden, Ying Xi, et al.. (2022). Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone. European Respiratory Journal. 61(4). 2200604–2200604. 15 indexed citations

11.

Cui, Heyang, Ning Ding, Cheng Chen, et al.. (2021). Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 650891–650891. 9 indexed citations

12.

Ding, Ning, Na Yin, Ying Xu, et al.. (2021). Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect. Pharmaceutical Research. 38(12). 2091–2108. 4 indexed citations

13.

Zhou, Ning, Min Zhou, Ning Ding, Qinglin Li, & Guangming Ren. (2021). An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma. Frontiers in Oncology. 11. 726742–726742. 3 indexed citations

14.

Jiang, Tao, Xiaobo Xu, Xiaojuan Chen, et al.. (2020). Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases. Translational Lung Cancer Research. 9(6). 2514–2517. 6 indexed citations

15.

Chu, Wei, Ning Ding, Qing Cai, et al.. (2018). Improving Plasma Stability and Bioavailability In Vivo of Gemcitabine Via Nanoparticles of mPEG-PLG-GEM Complexed with Calcium Phosphate. Pharmaceutical Research. 35(12). 230–230. 9 indexed citations

16.

Wei, Zong, Eiji Yoshihara, Nanhai He, et al.. (2018). Vitamin D Switches BAF Complexes to Protect β Cells. Cell. 173(5). 1135–1149.e15. 154 indexed citations

17.

Ding, Ning, Nasun Hah, Ruth T. Yu, et al.. (2015). BRD4 is a novel therapeutic target for liver fibrosis. Proceedings of the National Academy of Sciences. 112(51). 15713–15718. 171 indexed citations

18.

Ding, Ning, Christopher Liddle, Ronald M. Evans, & Michael Downes. (2013). Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?. Expert Review of Clinical Pharmacology. 6(6). 597–599. 19 indexed citations

19.

Ding, Ning, Yuan Gao, Ning Wang, & Hui Li. (2011). Functional analysis of the chicken PPARγ gene 5′-flanking region and C/EBPα-mediated gene regulation. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 158(4). 297–303. 20 indexed citations

20.

Ding, Ning, Chieri Tomomori‐Sato, Shigeo Sato, et al.. (2008). MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression. Journal of Biological Chemistry. 284(5). 2648–2656. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact